Donaldson reported record fiscal fourth-quarter 2026 sales and earnings as higher volumes, pricing, favorable mix, and the acquisition of Facet Filtration drove revenue growth and significant gross-margin improvement.
Fourth-quarter sales increased 8% year-over-year to $1.059 billion from $980.7 million.
Facet contributed approximately $30 million of quarterly revenue, while organic growth was supported by strength across Mobile Solutions and Life Sciences.
The quarter also produced substantial improvement in profitability.
GAAP gross margin expanded 180 basis points to 36.3% from 34.5%.
Adjusted gross margin increased to 36.7% from 34.8%, representing a 190-basis-point improvement.
Donaldson attributed the margin expansion primarily to higher volumes, pricing and favorable mix.
Those benefits were partially offset by increased input costs and continued production inefficiencies within Power Generation.
The results demonstrate meaningful operating leverage as the company converted higher sales into faster earnings growth despite absorbing acquisition-related dilution.
GAAP diluted earnings per share increased 13.4% year-over-year to $1.10.
Adjusted diluted EPS increased 11.7% to $1.15.
The adjusted result included approximately $0.06 per share of dilution associated with the Facet acquisition.
That means Donaldson generated double-digit adjusted EPS growth even while carrying integration and other costs related to the newly acquired business.
Facet Filtration has become an important component of Donaldson’s growth strategy.
The acquisition expands the company’s filtration capabilities and adds additional exposure to specialized markets.
Its approximately $30 million of fourth-quarter revenue represented a meaningful contribution to Donaldson’s overall growth during the period.
At the same time, the company continued producing organic gains from its existing businesses.
Mobile Solutions was a major contributor.
That business serves customers across transportation, off-road equipment and other mobile applications where filtration is required to protect engines and other systems from contaminants.
Life Sciences also contributed to organic growth.
Donaldson has been investing in Life Sciences as part of a broader strategy to expand beyond its traditional industrial and transportation filtration markets.
The segment provides filtration and separation technologies used across bioprocessing, food and beverage and other specialized applications.
The combination of established industrial businesses and faster-growing specialized markets gives Donaldson multiple avenues for expansion.
The company’s gross-margin performance was another important part of the quarter.
A 180-basis-point increase in GAAP gross margin represents a substantial improvement for a large industrial manufacturer.
Higher production volumes can provide leverage because fixed manufacturing costs are spread across a larger sales base.
Pricing can further improve profitability when the company is able to offset or exceed increases in raw materials and other input expenses.
Donaldson also benefited from product and customer mix, which can affect margins depending on the relative contribution of higher-value products and end markets.
Those gains were not without pressure.
Higher input costs continued affecting the business, while Power Generation production inefficiencies remained a headwind.
Manufacturing inefficiencies can create additional labor, material and overhead expenses and prevent factories from operating at their targeted productivity levels.
Donaldson’s ability to deliver significant overall margin expansion despite those issues suggests strength elsewhere in the portfolio more than compensated for the drag.
The fourth-quarter results capped a strong fiscal year.
Full-year sales increased 5.3% to approximately $3.9 billion.
GAAP diluted EPS increased 26.2% to $3.85.
The faster increase in earnings relative to revenue reflects a combination of margin expansion, operating leverage and other improvements across the business.
Donaldson enters fiscal 2027 expecting another record year.
The company projects sales growth between 5.5% and 9.5%.
At the midpoint, the outlook implies approximately 7.5% growth.
Management also expects diluted EPS between $4.22 and $4.38.
At the midpoint, that would represent approximately $4.30 per share.
The EPS outlook includes an estimated $0.12 per share of dilution associated with Facet.
That means Donaldson expects underlying earnings improvement to be strong enough to more than offset the near-term earnings impact from the acquisition.
Operating margin is also expected to improve.
Donaldson forecasts fiscal 2027 operating margin between 16.6% and 17.2%.
That compares with a fiscal 2026 GAAP operating margin of 15.4% and adjusted operating margin of 16%.
At the midpoint of the new outlook, operating margin would reach approximately 16.9%.
The expected expansion suggests management sees further opportunities to benefit from volume growth, pricing, manufacturing improvements and integration of acquired businesses.
One of the most dramatic growth areas in fiscal 2027 is expected to be Aerospace and Defense.
Donaldson projects sales in the category to increase more than 50%.
A large portion of that increase is expected to come from the Facet acquisition, but management also anticipates organic growth in the mid-teens.
That organic forecast indicates that Aerospace and Defense demand is expected to remain strong even before considering acquired revenue.
The segment could therefore become a more meaningful part of Donaldson’s overall business mix.
Aerospace and defense filtration applications generally involve demanding performance requirements, creating opportunities for specialized products that protect critical equipment and systems.
Such markets can also provide attractive long-term customer relationships because qualification processes and technical requirements can create higher barriers to switching suppliers.
The Facet acquisition gives Donaldson additional scale in these specialized areas.
As integration progresses, management may also have opportunities to expand Facet products through Donaldson’s global sales and distribution network.
Conversely, Donaldson could potentially introduce more of its existing products to Facet customer relationships.
Those cross-selling opportunities represent one potential source of longer-term acquisition synergies, although the company will first need to work through the near-term dilution reflected in its fiscal 2027 guidance.
Donaldson’s fiscal 2027 outlook implies that management expects both acquired and organic growth to continue.
The company is not relying exclusively on Facet to drive its forecast.
Organic opportunities across Mobile Solutions, Life Sciences and Aerospace and Defense are also expected to contribute.
Continued improvement in manufacturing productivity could provide another earnings driver.
Power Generation inefficiencies remained a drag during the fourth quarter, so progress in that area could help improve margins if operations normalize.
The projected operating-margin range of 16.6% to 17.2% already anticipates a step up from fiscal 2026.
That improvement would build on the strong gross-margin expansion delivered in the fourth quarter.
The company’s ability to maintain pricing will also remain important.
Higher pricing contributed to fiscal fourth-quarter margin improvement and helped offset rising input expenses.
Industrial companies frequently face timing differences between cost inflation and price increases, so maintaining appropriate pricing can be critical to protecting profitability.
Donaldson’s fiscal fourth-quarter results indicate that pricing and mix were sufficiently favorable to overcome both increased input costs and operational inefficiencies.
The quarter therefore provided evidence of stronger underlying earnings quality alongside revenue growth.
Sales increased 8%, but GAAP EPS increased 13.4%.
Gross margin expanded by 180 basis points, while adjusted gross margin improved by 190 basis points.
The earnings improvement was achieved despite approximately $0.06 per share of Facet-related dilution.
For the full year, the difference was even more pronounced.
Sales increased 5.3%, while GAAP EPS grew 26.2%.
That performance gives Donaldson a stronger earnings base heading into fiscal 2027.
The company now expects another year of record sales and earnings while continuing to integrate Facet and expand its higher-growth businesses.
Aerospace and Defense is expected to be a particularly important contributor, with more than 50% sales growth expected and organic growth projected in the mid-teens.
At the same time, Donaldson expects total company sales to increase between 5.5% and 9.5%.
If the company reaches the midpoint of that range, annual revenue would move meaningfully above the approximately $3.9 billion generated in fiscal 2026.
The expected EPS range of $4.22 to $4.38 would also establish another annual earnings record.
Importantly, those projections already incorporate approximately $0.12 per share of expected Facet dilution.
That suggests management expects the acquired business to create longer-term strategic value even though integration costs and other near-term factors will weigh on fiscal 2027 earnings.
Overall, Donaldson finished fiscal 2026 with strong momentum.
Fourth-quarter revenue exceeded $1 billion, gross margins improved materially and both GAAP and adjusted EPS reached record levels.
The Facet acquisition contributed immediate revenue while organic strength in Mobile Solutions and Life Sciences added to growth.
For fiscal 2027, Donaldson expects another step higher in sales, earnings and operating profitability, supported by acquisition contributions, mid-teens organic Aerospace and Defense growth and further improvements across its global filtration portfolio.
KEY QUOTE:
“We are forecasting another record year, including record sales, operating margin, and earnings.”
Rich Lewis, President and Chief Executive Officer of Donaldson
